Caren van Roekel

203 Dose-effect relationships of holmium-166 radioembolization in colorectal cancer 10. Kafrouni M, Allimant C, Fourcade M, Vauclin S, Delicque J, Ilonca AD, et al. Retrospective voxel-based dosimetry for assessing the ability of the body- surface-area model to predict delivered dose and radioembolization outcome. J Nucl Med. 2018;59(8):1289-95. Epub 2018/03/17. 11. Bastiaannet R, van Roekel C, Smits MLJ, Elias SG, van Amsterdam WAC, Doan DT, et al. First evidence for a dose-response relationship in patients treated with ( 166 ) Ho-radioembolization: a prospective study. J Nucl Med. 2019;61(4):608-12. Epub 2019/10/12. 12. SalemR, Thurston KG. Radioembolization with 90Yttrium microspheres: a state- of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17(8):1251-78. Epub 2006/08/23. 13. Klein S, Staring M, Murphy K, Viergever MA. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29:196-205. 14. Cancer IN. Common terminology criteria for adverse events (CTCAE) v5.0. Cancer Therapy Evaluation Program; 2018. 15. O JH, Lodge MA, Wahl RL. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology. 2016;280(2):576-84. 16. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47. Epub 2008/12/23. 17. Heinze G, Dunkler D. Avoiding infinite estimates of time-dependent effects in small-sample survival studies. Stat Med. 2008;30(27):6455-69. 18. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics. 1997;53(2):567-78. 19. Riaz A, Awais R, Salem R. Side effects of yttrium-90 radioembolization. Front Oncol. 2014;4:198. Epub 2014/08/15. 20. Kennedy AS, Ball D, Cohen SJ, Cohn M, Coldwell DM, Drooz A, et al. Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres. J Gastrointest Oncol. 2015;6(2):134-42. Epub 2015/04/02. 21. Hickey R, Lewandowski RJ, Prudhomme T, Ehrenwald E, Baigorri B, Critchfield J, et al. 90Y Radioembolization of colorectal hepatic metastases using glass microspheres: safety and survival outcomes from a 531-patient multicenter study. J Nucl Med. 2016;57(5):665-71. Epub 2015/12/05. 7